De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Medley Beheer

Beheer criteriumcontroles 1/4

De CEO Medley's is Kohei Takiguchi, benoemd in Jun2009, heeft een ambtstermijn van 15.33 jaar. bezit rechtstreeks 19.8% van de aandelen van het bedrijf, ter waarde ¥ 25.40B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 1.6 jaar en 6.6 jaar.

Belangrijke informatie

Kohei Takiguchi

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salaris	n/a
Dienstverband CEO	15.3yrs
Eigendom CEO	19.8%
Management gemiddelde ambtstermijn	1.6yrs
Gemiddelde ambtstermijn bestuur	6.6yrs

Recente managementupdates

Recent updates

Medley, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Aug 17

Industry Analysts Just Upgraded Their Medley, Inc. (TSE:4480) Revenue Forecasts By 10%

Feb 26

CEO

Kohei Takiguchi (40 yo)

15.3yrs

Tenure

Mr. Kohei Takiguchi serves as President, Chief Executive Officer and Director at Medley,Inc. since June 2009. Prior to establishing Medley, he established Gemeinschaft, Inc. a U. S. corporation and became...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Kohei Takiguchi	CEO, President & Director	15.3yrs	geen gegevens	19.8% ¥ 25.0b
Ryo Kawahara	Senior VP & Head of Finance Division and CFO	8.3yrs	geen gegevens	0.99% ¥ 1.3b
Daiki Okiyama	VP and Head of Accounting & Tax and Finance Division	1.5yrs	geen gegevens	geen gegevens
Sho Imanaka	Senior Vice President	2.9yrs	geen gegevens	geen gegevens
Masaya Hakiri	Vice President and Head of Design & Communication	less than a year	geen gegevens	geen gegevens
Noriyoshi Owari	VP & Head of Corporate Development and Finance Division	1.5yrs	geen gegevens	geen gegevens
Hayato Inakawa	Vice President & Head of Human Capital Division	1.5yrs	geen gegevens	geen gegevens
Yosuke Ishizaki	Senior VP & Head of HR Platform Business	1.8yrs	geen gegevens	geen gegevens
Takayuki Nakamura	Senior VP & Head of Medical Platform Business	2.9yrs	geen gegevens	geen gegevens
Ryusuke Inamoto	VP & CTO of HR Platform Business	1.8yrs	geen gegevens	geen gegevens
Hiroyuki Komatsu	VP & President of Pacific Medical	1.3yrs	geen gegevens	geen gegevens
Hiromune Shishido	CTO of Medical Platform Business & VP	less than a year	geen gegevens	geen gegevens

1.6yrs

Gemiddelde duur

Ervaren management: Het managementteam van 4480 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.6 jaar), wat duidt op een nieuw team.

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Kohei Takiguchi	CEO, President & Director	15.3yrs	geen gegevens	19.8% ¥ 25.0b
Ryo Kawahara	Senior VP & Head of Finance Division and CFO	8.3yrs	geen gegevens	0.99% ¥ 1.3b
Noboru Kotani	Independent External Director	6.6yrs	geen gegevens	0.13% ¥ 163.6m
Ryoko Nagata	External Corporate Auditor	1.6yrs	geen gegevens	geen gegevens
Masahide Kamachi	External Corporate Auditor	7.6yrs	geen gegevens	0.035% ¥ 44.4m
Shohei Omote	Full Time Auditor	8.8yrs	geen gegevens	geen gegevens
Rina Sakuraba	Independent External Director	1.6yrs	geen gegevens	geen gegevens
Reiko Nagatsuma	Independent External Director	1.6yrs	geen gegevens	geen gegevens
Keisuke Hioki	Independent External Director	1.6yrs	geen gegevens	geen gegevens

6.6yrs

Gemiddelde duur

44yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 4480 wordt beschouwd als ervaren (gemiddelde ambtstermijn 6.6 jaar).

Medley Beheer

Beheer criteriumcontroles 1/4

Belangrijke informatie

Recente managementupdates

Medley, Inc., Annual General Meeting, Mar 26, 2024

Medley, Inc., Annual General Meeting, Mar 29, 2023

Less than half of directors are independent

Less than half of directors are independent

Medley, Inc., Annual General Meeting, Mar 25, 2022

Recent updates

Medley, Inc. (TSE:4480) agreed to acquire Offshore Co., Ltd. from Nine States No. 4 Investment Limited Partnership and Fukuoka Capital Partners Co., Ltd. and three other shareholders for ¥2.6 billion.

Investor sentiment improves as stock rises 15%

Medley, Inc. to Report Q3, 2024 Results on Nov 14, 2024

Investor sentiment deteriorates as stock falls 17%

Medley, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now

Second quarter 2024 earnings: EPS and revenues miss analyst expectations

Medley, Inc.'s (TSE:4480) P/E Still Appears To Be Reasonable

Investor sentiment deteriorates as stock falls 23%

Investor sentiment improves as stock rises 18%

Medley, Inc. to Report Q2, 2024 Results on Aug 14, 2024

New minor risk - Share price stability

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

Is Medley, Inc. (TSE:4480) Trading At A 30% Discount?

With Medley, Inc. (TSE:4480) It Looks Like You'll Get What You Pay For

Now 22% undervalued after recent price drop

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Medley (TSE:4480) Seems To Use Debt Rather Sparingly

Now 21% overvalued after recent price rise

Consensus EPS estimates increase by 11%

Medley, Inc. to Report Q1, 2024 Results on May 14, 2024

Industry Analysts Just Upgraded Their Medley, Inc. (TSE:4480) Revenue Forecasts By 10%

Consensus revenue estimates increase by 10%

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Now 23% overvalued after recent price rise

Medley, Inc., Annual General Meeting, Mar 26, 2024

Investor sentiment improves as stock rises 15%

Medley, Inc. to Report Fiscal Year 2023 Results on Feb 14, 2024

Third quarter 2023 earnings: EPS and revenues exceed analyst expectations

Medley, Inc. (TSE:4480) agreed to acquire Lalune business of Ateam Wellness, K.K. for ¥500 million.

Consensus EPS estimates increase by 13%

Price target increased by 11% to JP¥6,625

Medley, Inc. to Report Q3, 2023 Results on Nov 14, 2023

Consensus EPS estimates increase by 23%

Price target increased by 24% to JP¥5,950

New minor risk - Earnings quality

Second quarter 2023 earnings released: EPS: JP¥47.30 (vs JP¥31.21 in 2Q 2022)

Consensus EPS estimates increase by 15%

Price target increased by 10% to JP¥4,950

Medley, Inc. (TSE:4480) agreed to acquire Gcm.Co.,Ltd.

Medley, Inc. to Report Q2, 2023 Results on Aug 14, 2023

Price target increased by 9.1% to JP¥4,800

Full year 2022 earnings: EPS exceeds analyst expectations

Full year 2022 earnings: EPS exceeds analyst expectations

Medley, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending December 31, 2023

Consensus EPS estimates fall by 12%

Medley, Inc., Annual General Meeting, Mar 29, 2023

Medley, Inc. to Report Fiscal Year 2022 Results on Feb 14, 2023

Price target increased to JP¥4,500

Less than half of directors are independent

Third quarter 2022 earnings released: JP¥0.38 loss per share (vs JP¥5.33 loss in 3Q 2021)

Medley, Inc. Revises Consolidated Earnings Guidance for the Fiscal Ending December 31, 2022

Medley, Inc. (TSE:4480) agreed to acquire Tenxia, inc. from Masashi Okabe and Taishi Mitsuji and others for approximately ¥260 million.

Medley, Inc. (TSE:4480) acquired Tenxia.

Medley, Inc. to Report Q3, 2022 Results on Nov 11, 2022

Second quarter 2022 earnings released: EPS: JP¥31.21 (vs JP¥21.70 in 2Q 2021)

Medley, Inc. Provides Consolidated Earnings Guidance for the Fiscal Ending December 31, 2022

Medley, Inc. to Report Q2, 2022 Results on Aug 12, 2022

First quarter 2022 earnings: EPS exceeds analyst expectations

Medley, Inc. Provides Consolidated Earnings Guidance for the Fiscal Ending December 31, 2022

Price target decreased to JP¥3,950

Less than half of directors are independent

Medley, Inc. to Report Q1, 2022 Results on May 13, 2022

Full year 2021 earnings: EPS exceeds analyst expectations

Medley, Inc. Provides Consolidated Earning Guidance for the Year Ending December 31, 2022

Medley, Inc., Annual General Meeting, Mar 25, 2022

Price target decreased to JP¥4,250

Third quarter 2021 earnings released: JP¥5.33 loss per share (vs JP¥2.81 profit in 3Q 2020)

Consensus forecasts updated

Second quarter 2021 earnings released: EPS JP¥21.72 (vs JP¥2.81 in 2Q 2020)

Consensus EPS estimates increase to JP¥14.56